Nordic walking for cardiovascular prevention in patients with ischaemic heart disease or metabolic syndrome

被引:4
|
作者
Vehi, Cristina [1 ]
Falces, Carles [1 ]
Angel Sarlat, Miquel [2 ]
Gonzalo, Ana [3 ]
Andrea, Rut [1 ]
Sitges, Marta [1 ]
机构
[1] Univ Barcelona, Inst Cardiovasc, Hosp Clin, Serv Cardiol, Barcelona, Spain
[2] Ctr Atencio Primaria Bordeta Magoria, Inst Catala Salut, Barcelona, Spain
[3] Ctr Atencio Primaria La Marina, Inst Catala Salut, Barcelona, Spain
来源
MEDICINA CLINICA | 2016年 / 147卷 / 12期
关键词
Nordic walking; Ischaemic heart disease; Prevention; Rehabilitation; SECONDARY PREVENTION; PHYSICAL-ACTIVITY;
D O I
10.1016/j.medcli.2016.09.041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: The incidence of atherosclerotic diseases has increased in Europe due in part to the population's sedentary lifestyle. Physical activity is useful for cardiovascular prevention. Nordic walking (NW) mobilizes a great number of muscular groups and is very popular in northern Europe. There is no data available on its impact in the healthcare system of the Mediterranean area. We propose the implementation of a NW program to promote physical activity and control cardiovascular risk factors (CVRF), as well as to improve quality of life and the adherence to medical treatment in patients with a chronic ischemic heart disease or metabolic syndrome. Methods: We selected patients with uncontrolled CVRFs. These patients performed 2 weekly sessions of NW over the course of one year. Baseline data extracted from the patients' medical history, quality of life questionnaires and on adherence to treatment was compared with the results obtained at the end of the program. Results:. A reduction in the rate of CVRFs from 4.78 to 3 was observed, with an evident trend towards the improvement of the patients' quality of life and a better adherence to the treatment. Conclusions: The implementation of a NW program is feasible in the public healthcare system and can aid in the management of CVRFs. (C) 2016 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:537 / 539
页数:3
相关论文
共 50 条
  • [41] Effects of nordic walking training on gait and exercise tolerance in male ischemic heart disease patients
    Szpala, Agnieszka
    Winiarski, Slawomir
    Kolodziej, Malgorzata
    Jasinski, Ryszard
    Lejczak, Andrzej
    Kalka, Dariusz
    Lorek, Karolina
    Balchanowski, Jacek
    Wudarczyk, Slawomir
    Wozniewski, Marek
    Pietraszewski, Bogdan
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [42] Prevalence of metabolic syndrome in patients with coronary heart disease
    Mijares, AH
    Fortuny, CR
    Izquierdo, ES
    Oliver, MJO
    Triguero, MLM
    Ariño, CM
    Suárez-Varela, MM
    MEDICINA CLINICA, 2003, 121 (06): : 204 - 208
  • [43] Do Mechatronic Poles Change the Gait Technique of Nordic Walking in Patients with Ischemic Heart Disease?
    Szpala, Agnieszka
    Winiarski, Slawomir
    Kolodziej, Malgorzata
    Pietraszewski, Bogdan
    Jasinski, Ryszard
    Niebudek, Tadeusz
    Lejczak, Andrzej
    Kalka, Dariusz
    Lorek, Karolina
    Balchanowski, Krzysztof
    Wudarczyk, Slawomir
    Wozniewski, Marek
    APPLIED BIONICS AND BIOMECHANICS, 2023, 2023
  • [44] Nordic walking versus walking without poles for rehabilitation with cardiovascular disease: Randomized controlled trial
    Girold, Sebastien
    Rousseau, Jerome
    Le Gal, Magalie
    Coudeyre, Emmanuel
    Le Henaff, Jacqueline
    ANNALS OF PHYSICAL AND REHABILITATION MEDICINE, 2017, 60 (04) : 223 - 229
  • [45] ISCHAEMIC HEART-DISEASE AND NEPHROTIC SYNDROME
    VERE, DW
    LANCET, 1969, 2 (7620): : 597 - &
  • [46] Ischaemic heart disease:: Inflammation markers and cardiovascular risk
    García-Moll, X
    Kaski, JC
    REVISTA ESPANOLA DE CARDIOLOGIA, 1999, 52 (11): : 990 - 1003
  • [47] Role of Ajwa in the treatment and prevention of ischaemic heart disease
    Khan, Muniba
    Siddiqui, Nadir
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2017, 67 (12) : 1954 - 1954
  • [48] Role of the polypill for secondary prevention in ischaemic heart disease
    Castellano, Jose M.
    Fuster, Valentin
    Jennings, Catriona
    Prescott, Eva
    Bueno, Hector
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 : 44 - 51
  • [49] Fenofibrate for Cardiovascular Disease Prevention in Metabolic Syndrome and Type 2 Diabetes Mellitus
    Steiner, George
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (12A): : 28L - 33L
  • [50] Exercise for prevention and treatment of cardiovascular disease, type 2 diabetes, and metabolic syndrome
    Gaesser G.A.
    Current Diabetes Reports, 2007, 7 (1) : 14 - 19